We are monitoring the impact of COVID-19 on APAC Preclinical CRO Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6466
Share on
Share on

Asia Pacific Preclinical CRO Market Research Report - Segmented By Service Type, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 6466
Pages: 145

Asia Pacific Preclinical CRO Market Size & Growth (2021 to 2026):

As per the research report, the size of the Asia Pacific Preclinical CRO Market was valued at USD 0.76 billion in 2021 and estimated to be growing at a CAGR of 8.59%, to reach USD 1.15 billion by 2026 during the forecast period 2021 to 2026. 

The APAC preclinical CRO agents market will show lucrative growth due to increased R&D spending and growing outsourcing trends. The increasing number of new drugs entering the preclinical phase is also expected to drive the market during the analysis period. The rising cost of research is very highly developed nations such as the United Kingdom, the U.S.A, Canada, etc., compared to developing countries in the APAC region.

This factor, coupled with other drivers such as strict regulations and pricing policies and significant budget cuts for biomedical research, has increased interest in outsourcing clinical trials. The APAC pharmaceutical market is growing faster than the rest of the world, but it has a sizeable skilled population. In addition, it has shown improvements in the regulatory environment, quickly making it a preferred outsourcing destination for clinical trials.

The increasing incidence of various chronic illnesses such as cancer, heart disease, neurological and infectious conditions further encourages biopharmaceutical companies to increase their investment in developing newer drugs with lesser side effects to meet the demand for preclinical CRO services. In addition, the number of recruiting centers indicates increased patient access for pharmaceutical companies. Hence, biopharmaceutical companies are adopting strategies to remain competitive and flexible in increasing knowledge, advanced technologies, and sustaining an unstable economical environment.

Cost estimates for conducting clinical trials have ranged from the US $ 200 million to over US $ 2 billion in recent years and continue to rise in the future. The average increase in the cost of conducting clinical trials is 7.23% above the average inflation rate over the past 20 years. This high cost will challenge the studied market in the years to come. In addition, due to stringent regulatory policies in APAC regions, biopharmaceuticals companies are facing difficulties in growing in the market.

This research report on the APAC Preclinical CRO Market has been segmented and sub-segmented into the following categories:

By Service Type:

  • bioanalysis And DMPK Studies
  • Toxicology Testing
  • Other Preclinical Services

By End User:

  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Medical Device Companies

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the China preclinical CRO market had market revenue of over $ 25- 38 billion dollars in 2007-2017 in the pharmaceutical industry. This growth can be attributed to robust research infrastructure, skilled labor, and a lenient regulatory approval system in China. In addition, China is home to several global pharmaceutical players, which have increased reliance on CROs for market penetration.

One of the greatest strengths of the Asia-Pacific preclinical CRO agents market is access to a large population with unmet medical treatment. Asia's emerging middle-class countries like the Philippines, Malaysia, and India are growing due to increased clinical trials in the Asia-Pacific region. Several multinational CROs agents in India have end-to-end development capabilities and partnerships with local stakeholders.

The Japanese preclinical CRO market has grown over the past ten years, reaching $ 4.5 billion in 2019. It has come a long way in reducing regulatory delays and increasing harmonization with the standardization of regulatory processes. The market is looking for unique and innovative drugs for acute diseases like regenerative drugs.

Other APAC regions such as Singapore and Australia will show consistent growth during the studied period, owing to high investments and growing demand for better healthcare infrastructure.

KEY MARKET PLAYERS

The Top companies leading in the APAC Preclinical CRO Market profiled in the report are Charles River Laboratories International, Inc.; Laboratory Corporation of America; Envigo, Eurofins Scientific; PRA Health Science, Inc.; Wuxi AppTec; Medpace, Inc.; Pharmaceutical Product Development, LLC.; and Paraxel International Corporation.,

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Service type                               

                                5.1.1 Introduction           

                                5.1.2 Bioanalysis and DMPK studies        

                                5.1.3 Toxicology testing

                                5.1.4 Other preclinical services  

                                5.1.5  Y-o-Y Growth Analysis, By service type      

                                5.1.6  Market Attractiveness Analysis, By service type    

                                5.1.7  Market Share Analysis, By service type     

                5.2 End user                      

                                5.2.1 Introduction           

                                5.2.2 Biopharmaceutical companies        

                                5.2.3 Government and academic institutes         

                                5.2.4 Medical device companies               

                                5.2.5 Y-o-Y Growth Analysis, By end user             

                                5.2.6 Market Attractiveness Analysis, By end user           

                                5.2.7 Market Share Analysis, By end user             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By service type

                                                6.1.3.3 By end user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By service type

                                                6.1.4.3 By end user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By service type

                                                6.1.5.3 By end user

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Charles River Laboratories International, Inc                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Laboratory Corporation of America                  

                8.3 Envigo                           

                8.4 Eurofins Scientific                    

                8.5 PRA Health Science, Inc                         

                8.6 Wuxi AppTec                             

                8.7 Medpace, Inc                            

                8.8 Pharmaceutical Product Development, LLC                  

                8.9 Paraxel International Corporation                    

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by end user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Preclinical CRO Market By Service type, From 2021 to 2026 ( USD Billion )
  2. Asia Pacific Bioanalysis and DMPK studies Market By Region, From 2021 to 2026 ( USD Billion )
  3. Asia Pacific Toxicology testing Market By Region, From 2021 to 2026 ( USD Billion )
  4. Asia Pacific Other preclinical services Market By Region, From 2021 to 2026 ( USD Billion )
  5. Asia Pacific Preclinical CRO Market By End user, From 2021 to 2026 ( USD Billion )
  6. Asia Pacific Biopharmaceutical companies Market By Region, From 2021 to 2026 ( USD Billion )
  7. Asia Pacific Govermenta and academic institutes Market By Region, From 2021 to 2026 ( USD Billion )
  8. Asia Pacific Medical device companies Market By Region, From 2021 to 2026 ( USD Billion )
  9. Japan Preclinical CRO Market By Service type, From 2021 to 2026 ( USD Billion )
  10. Japan Preclinical CRO Market By End user, From 2021 to 2026 ( USD Billion )
  11. China Preclinical CRO Market By Service type, From 2021 to 2026 ( USD Billion )
  12. China Preclinical CRO Market By End user, From 2021 to 2026 ( USD Billion )
  13. India Preclinical CRO Market By Service type, From 2021 to 2026 ( USD Billion )
  14. India Preclinical CRO Market By End user, From 2021 to 2026 ( USD Billion )
  15. Australia Preclinical CRO Market By Service type, From 2021 to 2026 ( USD Billion )
  16. Australia Preclinical CRO Market By End user, From 2021 to 2026 ( USD Billion )
  17. South Korea Preclinical CRO Market By Service type, From 2021 to 2026 ( USD Billion )
  18. South Korea Preclinical CRO Market By End user, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample